{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T19:02:01Z","timestamp":1787079721962,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1049870"],"award-info":[{"award-number":["APP1049870"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106697"],"award-info":[{"award-number":["APP1106697"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106697"],"award-info":[{"award-number":["APP1106697"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106697"],"award-info":[{"award-number":["APP1106697"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF16017"],"award-info":[{"award-number":["MCRF16017"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["COF11_04"],"award-info":[{"award-number":["COF11_04"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying soluble factors that influence epidermal integrity is critical for the development of preventative and therapeutic strategies for disorders such as ichthyosis, psoriasis, dermatitis and epidermal cancers. The transcription factor Grainyhead-like 3 (GRHL3) is essential for maintaining barrier integrity and preventing development of cutaneous squamous cell carcinoma (SCC); however, how loss of this factor, which in the skin is expressed exclusively within suprabasal epidermal layers triggers proliferation of basal keratinocytes, had thus far remained elusive. Our present study identifies thymus and activation-regulated chemokine (TARC) as a novel soluble chemokine mediator of keratinocyte proliferation following loss of <jats:italic>GRHL3<\/jats:italic>. Knockdown of <jats:italic>GRHL3<\/jats:italic> in human keratinocytes showed that of 42 cytokines examined, TARC was the only significantly upregulated chemokine. Mouse skin lacking <jats:italic>Grhl3<\/jats:italic> presented an inflammatory response with hallmarks of TARC activation, including heightened induction of blood clotting, increased infiltration of mast cells and pro-inflammatory T cells, increased expression of the pro-proliferative\/pro-inflammatory markers CD3 and pSTAT3, and significantly elevated basal keratinocyte proliferation. Treatment of skin cultures lacking <jats:italic>Grhl3<\/jats:italic> with the broad spectrum anti-inflammatory 5-aminosalicylic acid (<jats:italic>5ASA<\/jats:italic>) partially restored epidermal differentiation, indicating that abnormal keratinocyte proliferation\/differentiation balance is a key driver of barrier dysfunction following loss of <jats:italic>Grhl3<\/jats:italic>, and providing a promising therapeutic avenue in the treatment of <jats:italic>GRHL3<\/jats:italic>-mediated epidermal disorders.<\/jats:p>","DOI":"10.1038\/s41419-018-0901-6","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T07:33:21Z","timestamp":1539934401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Loss of GRHL3 leads to TARC\/CCL17-mediated keratinocyte proliferation in the epidermis"],"prefix":"10.1038","volume":"9","author":[{"given":"Stephen J.","family":"Goldie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denny L.","family":"Cottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraya","family":"Roslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren D.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Auden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Darido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"901_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","volume":"7","author":"GK Perera","year":"2012","unstructured":"Perera, G. K., Di Meglio, P. & Nestle, F. O. Psoriasis. Annu. Rev. Pathol. 7, 385\u2013422 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"901_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi, E., Schmidt, R. & Melino, G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6, 328\u2013340 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"901_CR3","first-page":"1119","volume":"13","author":"M Schmuth","year":"2015","unstructured":"Schmuth, M., Blunder, S., Dubrac, S., Gruber, R. & Moosbrugger-Martinz, V. Epidermal barrier in hereditary ichthyoses, atopic dermatitis, and psoriasis. J. Dtsch. Dermatol. Ges. 13, 1119\u20131123 (2015).","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"44","key":"901_CR4","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1038\/onc.2016.84","volume":"35","author":"C Darido","year":"2016","unstructured":"Darido, C., Georgy, S. R. & Jane, S. M. The role of barrier genes in epidermal malignancy. Oncogene 35, 5705\u20135712 (2016).","journal-title":"Oncogene"},{"key":"901_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/1346-8138.12440","volume":"41","author":"Y Kataoka","year":"2014","unstructured":"Kataoka, Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J. Dermatol. 41, 221\u2013229 (2014).","journal-title":"J. Dermatol."},{"key":"901_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/hmg\/ddu459","volume":"24","author":"DL Cottle","year":"2015","unstructured":"Cottle, D. L. et al. Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. Hum. Mol. Genet. 24, 436\u2013449 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1126\/science.1107511","volume":"308","author":"SB Ting","year":"2005","unstructured":"Ting, S. B. et al. A homolog of Drosophila grainy head is essential for epidermal integrity in mice. Science 308, 411\u2013413 (2005).","journal-title":"Science"},{"key":"901_CR8","doi-asserted-by":"publisher","first-page":"13670","DOI":"10.3390\/ijms140713670","volume":"14","author":"M Cangkrama","year":"2013","unstructured":"Cangkrama, M., Ting, S. B. & Darido, C. Stem cells behind the barrier. Int. J. Mol. Sci. 14, 13670\u201313686 (2013).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"901_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ydbio.2006.07.015","volume":"299","author":"Zhengquan Yu","year":"2006","unstructured":"Yu, Z. et al. The Grainyhead-like epithelial transactivator Get-1\/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4. Dev. Biol. 299, 122\u2013136 (2006).","journal-title":"Developmental Biology"},{"issue":"7","key":"901_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jid.2016.02.806","volume":"136","author":"Michael Cangkrama","year":"2016","unstructured":"Cangkrama, M. et al. Two ancient gene families are critical for maintenance of the mammalian skin barrier in postnatal life. J. Invest. Dermatol. 136, 1438\u20131448 (2016).","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"901_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccr.2011.10.014","volume":"20","author":"Charbel Darido","year":"2011","unstructured":"Darido, C. et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell. 20, 635\u2013648 (2011).","journal-title":"Cancer Cell"},{"key":"901_CR12","doi-asserted-by":"publisher","first-page":"djv152","DOI":"10.1093\/jnci\/djv152","volume":"107","author":"SR Georgy","year":"2015","unstructured":"Georgy, S. R. et al. Identification of a novel proto-oncogenic network in head and neck squamous cell carcinoma. J. Natl. Cancer Inst. 107, djv152 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"901_CR13","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1172\/JCI77138","volume":"124","author":"WM Gordon","year":"2014","unstructured":"Gordon, W. M. et al. A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia. J. Clin. Invest. 124, 5205\u20135218 (2014).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"901_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.devcel.2010.06.008","volume":"19","author":"Jacinta Caddy","year":"2010","unstructured":"Caddy, J. et al. Epidermal wound repair is regulated by the planar cell polarity signaling pathway. Dev. Cell. 19, 138\u2013147 (2010).","journal-title":"Developmental Cell"},{"issue":"1","key":"901_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ydbio.2013.08.004","volume":"382","author":"Marta H. Lesko","year":"2013","unstructured":"Lesko, M. H., Driskell, R. R., Kretzschmar, K., Goldie, S. J. & Watt, F. M. Sox2 modulates the function of two distinct cell lineages in mouse skin. Dev. Biol. 382, 15\u201326 (2013).","journal-title":"Developmental Biology"},{"key":"901_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1067\/mai.2002.126079","volume":"110","author":"T Fujisawa","year":"2002","unstructured":"Fujisawa, T. et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J. Allergy Clin. Immunol. 110, 139\u2013146 (2002).","journal-title":"J. Allergy Clin. Immunol."},{"key":"901_CR17","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/eji.200535564","volume":"36","author":"Y Tsunemi","year":"2006","unstructured":"Tsunemi, Y. et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur. J. Immunol. 36, 2116\u20132127 (2006).","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"901_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1523-1747.2000.00115.x","volume":"115","author":"Christian Vestergaard","year":"2000","unstructured":"Vestergaard, C. et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA\u2009+\u2009CCR4\u2009+\u2009lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115, 640\u2013646 (2000).","journal-title":"Journal of Investigative Dermatology"},{"key":"901_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gut.33.10.1353","volume":"33","author":"B Crotty","year":"1992","unstructured":"Crotty, B., Rosenberg, W. M., Aronson, J. K. & Jewell, D. P. Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease. Gut 33, 1353\u20131357 (1992).","journal-title":"Gut"},{"key":"901_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","volume":"116","author":"GC Kaiser","year":"1999","unstructured":"Kaiser, G. C., Yan, F. & Polk, D. B. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes. Gastroenterology 116, 602\u2013609 (1999).","journal-title":"Gastroenterology"},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"21514","DOI":"10.1074\/jbc.271.35.21514","volume":"271","author":"T Imai","year":"1996","unstructured":"Imai, T. et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 271, 21514\u201321521 (1996).","journal-title":"J. Biol. Chem."},{"key":"901_CR22","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","volume":"272","author":"T Imai","year":"1997","unstructured":"Imai, T. et al. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272, 15036\u201315042 (1997).","journal-title":"J. Biol. Chem."},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0049-3848(00)00402-3","volume":"101","author":"S Abi-Younes","year":"2001","unstructured":"Abi-Younes, S., Si-Tahar, M. & Luster, A. D. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb. Res. 101, 279\u2013289 (2001).","journal-title":"Thromb. Res."},{"key":"901_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood.V97.4.937","volume":"97","author":"AR Gear","year":"2001","unstructured":"Gear, A. R. et al. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 97, 937\u2013945 (2001).","journal-title":"Blood"},{"key":"901_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/00000478-200107000-00011","volume":"25","author":"SC Peh","year":"2001","unstructured":"Peh, S. C., Kim, L. H. & Poppema, S. TARC, a CC chemokine, is frequently expressed in classic Hodgkin\u2019s lymphoma but not in NLP Hodgkin\u2019s lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am. J. Surg. Pathol. 25, 925\u2013929 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"901_CR26","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/01.MP.0000021006.53593.B0","volume":"15","author":"MH Vermeer","year":"2002","unstructured":"Vermeer, M. H. et al. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin\u2019s disease. Mod. Pathol. 15, 838\u2013844 (2002).","journal-title":"Mod. Pathol."},{"key":"901_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0729-9","volume":"33","author":"F Zhu","year":"2016","unstructured":"Zhu, F. et al. Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma. Med. Oncol. 33, 17 (2016).","journal-title":"Med. Oncol."},{"key":"901_CR28","first-page":"3072","volume":"5","author":"LB Liu","year":"2015","unstructured":"Liu, L. B. et al. Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell. Am. J. Cancer Res. 5, 3072\u20133084 (2015).","journal-title":"Am. J. Cancer Res."},{"key":"901_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/cas.12505","volume":"105","author":"JB Lim","year":"2014","unstructured":"Lim, J. B., Kim, D. K. & Chung, H. W. Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker. Cancer Sci. 105, 1327\u20131333 (2014).","journal-title":"Cancer Sci."},{"key":"901_CR30","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1111\/ijd.12830","volume":"54","author":"CY Gu","year":"2015","unstructured":"Gu, C. Y., Gu, L. & Dou, X. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis. Int. J. Dermatol. 54, e261\u2013e265 (2015).","journal-title":"Int. J. Dermatol."},{"key":"901_CR31","doi-asserted-by":"crossref","unstructured":"Morita, E. et al. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. Allergy 65, 1166\u20131172 (2010).","DOI":"10.1111\/j.1398-9995.2010.02361.x"},{"key":"901_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/1346-8138.12273","volume":"40","author":"S Inui","year":"2013","unstructured":"Inui, S., Noguchi, F., Nakajima, T. & Itami, S. Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata. J. Dermatol. 40, 881\u2013885 (2013).","journal-title":"J. Dermatol."},{"key":"901_CR33","doi-asserted-by":"crossref","unstructured":"Ono, S., Nakajima, S., Otsuka, A., Miyachi, Y. & Kabashima, K. Pigmented purpuric dermatitis with high expression levels of serum TARC\/CCL17 and epidermal TSLP. Eur. J. Dermatol. 23, 701\u2013702 (2013).","DOI":"10.1684\/ejd.2013.2161"},{"key":"901_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/labinvest.3780242","volume":"81","author":"JB Rottman","year":"2001","unstructured":"Rottman, J. B., Smith, T. L., Ganley, K. G., Kikuchi, T. & Krueger, J. G. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab. Invest. 81, 335\u2013347 (2001).","journal-title":"Lab. Invest."},{"issue":"2","key":"901_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","volume":"43","author":"Hidehisa Saeki","year":"2006","unstructured":"Saeki, H. & Tamaki, K. Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases. J. Dermatol. Sci. 43, 75\u201384 (2006).","journal-title":"Journal of Dermatological Science"},{"issue":"1","key":"901_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1067\/mjd.2003.132","volume":"48","author":"Takashi Kakinuma","year":"2003","unstructured":"Kakinuma, T. et al. Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J. Am. Acad. Dermatol. 48, 23\u201330 (2003).","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"901_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1067\/mai.2001.113237","volume":"107","author":"Takashi Kakinuma","year":"2001","unstructured":"Kakinuma, T. et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107, 535\u2013541 (2001).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"901_CR38","doi-asserted-by":"publisher","first-page":"19903","DOI":"10.1073\/pnas.1007404107","volume":"107","author":"EN Arwert","year":"2010","unstructured":"Arwert, E. N. et al. Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate. Proc. Natl Acad. Sci. USA 107, 19903\u201319908 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0901-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0901-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:27:07Z","timestamp":1671539227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0901-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0901-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L.C. and I.M.S. are inventors on patent application WO 2016\/145488 A1 (PCT\/AU2016\/050185) related to 5ASA treatment of skin diseases and receive funding from Factor Therapeutics Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1072"}}